Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β -1a.
Postural Motor Learning Deficits in People With MS in Spatial but Not Temporal Control of Center of Mass.
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
Bone mineral density levels in adults with multiple sclerosis: A meta-analysis.
Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases.
Alterations in tight junction protein and IgG permeability accompany leukocyte extravasation across the choroid plexus during neuroinflammation.
Evidence of Oxidative Stress in Very Long Chain Fatty Acid - Treated Oligodendrocytes and Potentialization of Ros Production Using Rna Interference Directed Knockdown of Abcd1 and Acox1 Peroxisomal Proteins.
Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
The Challenges, Advantages, and Future of Phenome-Wide Association Studies.
Myoinositol trends in different types of brain lesions.
Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.
Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections.
Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide.
Microglia-blood vessel interactions: a double-edged sword in brain pathologies.
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
A case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion.
[Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice.]
Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3β Signaling.
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.
SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.
Mini Balance Evaluation Systems Test in people with multiple sclerosis: Reflects imbalance but may not predict falls.
The Effect of Neural Lesion Type on Botulinum Toxin Dosage: A Retrospective Chart Review.
Auditory function in children with Charcot-Marie-Tooth disease.
Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry.
Pages
« first
‹ previous
…
677
678
679
680
681
682
683
684
685
…
next ›
last »